NCT04038008View on ClinicalTrials.gov

Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 26, 2019

Primary Completion Date

September 17, 2019

Study Completion Date

January 13, 2020

Conditions

Bioequivalence

Interventions

DRUG

Fluconazole

Fluconazole is manufactured by Pharmtechnology LLC, Republic of Belarus. Each tablet contains 200 mg of fluconazole.

DRUG

Diflucan®

Diflucan® is manufactured by Fareva Amboise, France (MAH: PFIZER PHARMA PFE GmbH, Germany). Each hard capsule contains 200 mg of fluconazole.

Trial Locations (1)

H3P 3P1

Altasciences Company Inc., Mount Royal

All Listed Sponsors

collaborator

Altasciences Company Inc.

INDUSTRY

lead

Pharmtechnology LLC

INDUSTRY

NCT04038008 - Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter